×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Concord Biotech Limited | 2589.5 | 759.21 | 2442.2 | 7.26 | 17,264 | 52.9 |
| ASTRAZENECA PHARMA INDIA LTD. | 4482.71 | 308.51 | 4402.89 | 12.34 | 17176 | 102.0 |
| ALEMBIC PHARMACEUTICALS LTD. | 17022.47 | 1376.95 | 16927.43 | 7.01 | 15792 | 26.6 |
Concord Biotech Limited, with Security Code 543960, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Sales | 194.8 | 262.3 | 240.7 | 318.9 | 215.8 | 310.1 |
| Expenses | 122.7 | 143.2 | 134.9 | 184.7 | 134.5 | 173.5 |
| Operating Profit | 72.2 | 119.2 | 105.9 | 134.3 | 81.3 | 136.7 |
| OPM % | 37.03% | 45.43% | 43.99% | 42.1% | 37.66% | 44.06% |
| Other Income | 6.7 | 8.1 | 8.2 | 10.8 | 10.3 | 10.0 |
| Interest | 0.8 | 0.8 | 0.5 | 0.5 | 0.2 | 0.1 |
| Depreciation | 13.0 | 13.3 | 13.5 | 13.7 | 13.2 | 13.3 |
| Profit before tax | 65.0 | 113.2 | 100.1 | 130.9 | 78.2 | 133.3 |
| Tax % | 25.4% | 25.3% | 25.5% | 25.7% | 25.5% | 26% |
| Net Profit | 48.5 | 84.5 | 74.6 | 97.2 | 58.2 | 98.7 |
| EPS in Rs | 4.63 | 8.08 | 7.13 | 9.29 | 5.57 | 9.43 |
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Sales | 194.8 | 262.3 | 240.8 | 319.0 | 215.8 | 310.2 | 244.2 |
| Expenses | 122.7 | 146.6 | 134.9 | 186.9 | 134.5 | 176.5 | 146.3 |
| Operating Profit | 72.1 | 115.7 | 105.9 | 132.1 | 81.3 | 133.7 | 98.0 |
| OPM % | 37% | 44.1% | 44% | 41.4% | 37.7% | 43.1% | 40.1% |
| Other Income | 6.7 | 8.1 | 8.2 | 10.8 | 10.3 | 10.0 | 14.7 |
| Interest | 0.8 | 0.8 | 0.5 | 0.5 | 0.2 | 0.1 | 0.1 |
| Depreciation | 13.0 | 13.3 | 13.5 | 13.7 | 13.2 | 13.3 | 13.3 |
| Profit before tax | 65.0 | 109.7 | 100.1 | 128.7 | 78.2 | 130.3 | 99.3 |
| Tax % | 25.4% | 25.3% | 25.5% | 25.7% | 25.5% | 26% | 25.4% |
| Net Profit | 54.5 | 81.0 | 77.6 | 95.0 | 59.6 | 95.7 | 75.9 |
| EPS in Rs | 5 | 7 | 7 | 9 | 5 | 9 | 7 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 20% |
| 3 Years: | 9% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 12% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 18% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 9% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 12% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|